Cardiac Biomarkers Market 2022: Global Technology, Segmentation, Growth, Develop

Posted by Ankit Dwivedi on April 7th, 2022

Cardiac Biomarkers Market Global Industry Analysis, Potential Growth, Key Players, Latest Trends

For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233

Fortune Business Insights has further profiled some of the prominent market players operating in the global cardiac biomarkers market. They are as follows:

• Thermo Fisher Scientific
• Abbott
• Becton
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd.
• Randox Laboratories Ltd.
• Beckman Coulter, Inc.
• Dickinson and Company
• Dickinson and Company
• bioMérieux SA
• Other key market players

Global Cardiac Biomarkers Market Segmentation

By Type            

• Troponin
• Creatine kinase-MB (CK-MB)
• B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
• Myoglobin
• Others

By Application

• Acute Coronary Syndrome
• Myocardial Infarction
• Congestive Heart Failure
• Others

By End User     

• Hospitals
• Diagnostic Centers
• Homecare Settings
• Others

By Geography

• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)